Clear Guidance Sought On Medical Gas Issues

Johnson, Carl
November 2002
Gases & Welding Distributor;Nov/Dec2002 2003 Directory, p61
Trade Publication
Details the terms under the contract between CGA company and the U.S. Food and Drug Administration. Compliance of the medical gas firms with the current good manufacturing practice regulations; Development of various guidelines; Validation requirements for air separation units.


Related Articles

  • QbD impact minimal so far.  // Pharmaceutical Technology;Aug2010 Supplement, ps14 

    The article focuses on the impact of the U.S. Food and Drug Administration's quality-by-design (QbD) initiative on the nature of the work being requested of and performed by contract development organizations.

  • Refrigerant Issue Could Cost SLBG more than $10 million.  // Snack Food & Wholesale Bakery;Aug2003, Vol. 92 Issue 8, p8 

    Reports developments in the snack food industry as of August 2003. Terms of the agreement signed between Sara Lee Bakery Group company and the U.S. Environmental Protection Agency; Elimination of the snack food label requirement by the U.S. Food and Drug Administration; Distribution of...

  • FDA Awards NIPTE $1.19 Million Contract to Help Develop QbD Guidance.  // BioPharm International;Dec2008, Vol. 21 Issue 12, p16 

    The article reports that the National Institute for Pharmaceutical Technology and Education (NIPTE) has been awarded around $1.19 million contract by the U.S. Food and Drug Administration (FDA). The contract is aimed at developing the science behind the design space specifications for the...

  • FDA Recommendations to Industry Regarding Outsourcing. Swider, Marlen Garcia // BioPharm International;Apr2009 Supplement, p6 

    The article discusses guidance from the U.S. Food and Drug Administration on how to ensure compliance in outsourcing. The economic conditions that affect the capability of drug manufacturers to perform manufacturing operations at their establishments are tackled. The complexity that outsourcing...

  • Less foreign inspection likely.  // FDA Consumer;Sep/Oct97, Vol. 31 Issue 6, p5 

    Looks at the agreements reducing the need for US Food and Drug Administration (FDA) inspection of regulated firms in European Union (EU) countries. How the agreements can help FDA and EU agencies; Status of FDA in the agreements.

  • Industry, FDA agree on $100 million in fees.  // Medical Marketing & Media;May2002, Vol. 37 Issue 5, p35 

    Reports on the agreement between the U.S. Food and Drug Administration with the Biotechnology Industry Organization and the Pharmaceutical Research and Manufacturers of America on the renewal of the Prescription Drug User Fee Act. Increase in user fees in 2003; Use of the funds to invigorate...

  • Acusphere, FDA come to terms with firm's polymer application.  // Medical Device Daily;6/9/2011, Vol. 15 Issue 111, p5 

    The article reports that Acusphere in Lexington, Massachusetts has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a new Phase 3 study of its Imagify Peflubutane Polymer Microspheres for Injectable Suspension, the lead product candidate of Acusphere.

  • Regulatory Update.  // CenterWatch Monthly;Nov2015, Vol. 22 Issue 11, p4 

    An excerpt from the article "CRO Warning Letter From FDA Instructional to Sponsors on Overseeing CROs" is presented, which appears in the Volume 16, Number 5, September-October 2015 of "Research Practitioner" magazine.

  • FDA Issues Final Guidance on Quality Agreements. Wright, Tim // Contract Pharma;Jan/Feb2017, Vol. 19 Issue 1, p14 

    The article discusses the document titled "Contract Manufacturing Arrangements for Drugs: Quality Agreements" issued by the U.S. Food and Drug Administration (FDA) that recommends owners and contract manufacturers to implement written quality agreements to define manufacturing activities.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics